Protaphane® HM (Protaphane® HM)

Protafan ® HM Penfill ®

Omume ọgwụ

Ọ na - emekọrịta ihe na ihe dị mkpa ga - anabata plasma membrane receptor ma banye n’ime sel, ebe ọ na - eme ka phosphorylation nke protein cellular, na - akpali glycogen synthetase, pyruvate dehydrogenase, hexokinase, na-egbochi adipose anụ ahụ lipase na lipoprotein lipase. Na njikọta otu nnabata, ọ na - eme ka glucose na - abanye n’ime sel, na - eme ka nkwalite ya na uru ya na - akwalite ntụgharị na glycogen. Na-eme ka akwara glycogen nwee ike, na-akpali njikọ peptide.

Ọgwụ mlọ Ọgwụ

Mmetụta ahụ na-ebido n'ime elekere 1,5 mgbe sc nchịkwa, rute kacha elu mgbe elekere 4-12 wee dịgide ruo awa 24. A na-eji Protafan NM Penfill maka ọrịa shuga na-akpata insulin na-abụ insulin basal yana insulin na-eme obere ihe, maka insulin na-adabere , yana njikọ yana insulins na-eme ngwa ngwa.

Mmekorita

A na - eme ka mmetụta hypoglycemic dị elu site na acetylsalicylic acid, mmanya, alfa na beta blockers, amphetamine, steeti anabolic, clofibrate, cyclophosphamide, phenfluramine, fluoxetine, ifosfamide, MAO inhibitors, methyldopa, tetracycline, trifama, triigamamyin triigam, triigamamyin, rita, thiazides), glucocorticoids, heparin, mgbochi mgbochi homonụ, isoniazid, carbon lithium, nicotinic acid, phenothiazines, sympathomimetics, tricyclic antidepressants.

Usoro onunu ogwu na nhazi

Protafan ® HM Penfill ®

P / c. Ezubere ọgwụ a maka nchịkwa okpuru ala. Enweghị ike ịbanye na insulin insulin.

A na-ahọrọ ọ̀gwụ nke ọgwụ n’otu n’otu, na-eburu n'uche mkpa ndị ọrịa. Dị ka ọ dị, chọrọ insulin dị n'etiti 0.3 na 1 IU / kg / ụbọchị. Needchọrọ insulin kwa ụbọchị nwere ike ịdị elu karịa na ndị ọrịa nwere nguzogide insulin (dịka ọmụmaatụ, n'oge oge uto, yana na ndị ọrịa na-ebu oke ibu), na-agbadata na ndị ọrịa nwere ọgwụ insulin na-apụtakarị ihe.

Enwere ike iji Protafan ® NM na monotherapy yana yana insulin ngwa ngwa ma ọ bụ nke dị mkpụmkpụ.

A na-enyekarị Protafan ® HM subcutaneously na mpaghara apata ụkwụ. Ọ bụrụ na ọ dabara adaba, mgbe ahụ injections nwekwara ike ime na ogiri mgbịrịgba ihu, na mpaghara gluteal ma ọ bụ mpaghara mpaghara akwara dị mma nke ubu. Site na ntinye ọgwụ banyere mpaghara apata ụkwụ, a na-ahụ ka amachibidoro nwayọ karịa karịa iwebata mpaghara ndị ọzọ. Ọ bụrụ ntụtụ ka ejiri n'oghere gbatịa anụ ahụ, belata ọghọm nchịkwa ọbara intramuscular nke ọgwụ na-ebelata.

Mkpịsị ahụ kwesịrị ịdị n’okpuru anụ ahụ ma ọ dịkarịa ala 6 sekọnd, nke na-ekwe nkwa ị aụ ọgwụ zuru oke. Okwesiri igbanwe ebe igba ogwu n’etiti mpaghara anatomical iji gbochie mmepe nke lipodystrophy.

Emebere Protafan ® NM Penfill ® maka iji insulin inspekt Novo Nordisk yana agịga NovoFine ® ma ọ bụ NovoTvist ®. Ekwesịrị ịchọpụta nkọwa zuru ezu maka ojiji na nchịkwa nke ọgwụ ahụ.

Ọrịa concoitant, nke na-efe efe ma na-efe efe, na -emekarị ahụ insulin nwere ahụ. Ọ ga-adị mkpa imeghari dose ma ọ bụrụ na onye ọrịa ahụ nwere ọrịa ndị akụrụ, akụrụ, ọrụ akwara, pisis gland ma ọ bụ azụ gland. Mkpa maka ịhazigharị dose nwekwara ike ibili mgbe ị na-agbanwe mmega ahụ ma ọ bụ nri ndị ọrịa na-emebu. Imezi dose mgbe ị na-ebufe onye ọrịa n’otu ụdị insulin na nke ọzọ

Dodoụbiga ya ókè

Ọrịa mmepe nke hypoglycemia (ọsụsọ oyi, palpitations, ịma jijiji, agụụ, oke iwe, mgbakasị ahụ, isi ọwụwa, ụkwara ume ọkụ, enweghị mmeghari, ikwu okwu na nkwarụ ọhụụ, ịda mba). Nnukwu hypoglycemia nwere ike ibute mmebi nke ọrụ ụbụrụ, coma, na ọnwụ ruo nwa oge ma ọ bụ nke na-adịgide adịgide.

Ọgwụgwọ: shuga ma ọ bụ ihe glucose dị n'ime (ọ bụrụ na onye ọrịa maara), s / c, i / m ma ọ bụ iv - glucagon ma ọ bụ iv - glucose.

Mpempe mwepụta

Nkwụsị nke nchịkwa subcutaneous, 100 IU / ml (vials). N'ime karama iko hydrolytic klas nke 1, ejiri aka na ndị na-akwụsị akwụsị na roba bromobutyl / polyisolorida na okpu plastik, 10 ml ọ bụla, na mkpọ nke kaadiboodu 1 fl.

Nkwụsị nke nchịkwa subcutaneous, 100 IU / ml (katrized). N'ime katrized iko 3 ml Penfill,, katrized 5 na blisters, mkpọ chara acha 1 na kaadiboodu.